pcDNA3.1-hNurr1-NE Citations (7)

Originally described in: Shu Leong Ho Plasmids
Shu Leong Ho unpublished

Articles Citing pcDNA3.1-hNurr1-NE

Articles
HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer. Wan PK, Leung TH, Siu MK, Mo XT, Tang HW, Chan KK, Cheung AN, Ngan HY. Cancer Lett. 2021 Jan 28;497:14-27. doi: 10.1016/j.canlet.2020.09.025. Epub 2020 Sep 30. PubMed
Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries. Willems S, Muller M, Ohrndorf J, Heering J, Proschak E, Merk D. ChemMedChem. 2022 Apr 20;17(8):e202200026. doi: 10.1002/cmdc.202200026. Epub 2022 Feb 21. PubMed
Nurr1 Modulation Mediates Neuroprotective Effects of Statins. Willems S, Marschner JA, Kilu W, Faudone G, Busch R, Duensing-Kropp S, Heering J, Merk D. Adv Sci (Weinh). 2022 Jun;9(18):e2104640. doi: 10.1002/advs.202104640. Epub 2022 Apr 30. PubMed
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications. Vietor J, Gege C, Stiller T, Busch R, Schallmayer E, Kohlhof H, Hofner G, Pabel J, Marschner JA, Merk D. J Med Chem. 2023 May 11;66(9):6391-6402. doi: 10.1021/acs.jmedchem.3c00415. Epub 2023 Apr 26. PubMed
De Novo Design of Nurr1 Agonists via Fragment-Augmented Generative Deep Learning in Low-Data Regime. Ballarotto M, Willems S, Stiller T, Nawa F, Marschner JA, Grisoni F, Merk D. J Med Chem. 2023 Jun 22;66(12):8170-8177. doi: 10.1021/acs.jmedchem.3c00485. Epub 2023 May 31. PubMed
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand Dihydroxyindole. Sai M, Vietor J, Kornmayer M, Egner M, Lopez-Garcia U, Hofner G, Pabel J, Marschner JA, Wein T, Merk D. J Med Chem. 2023 Oct 12;66(19):13556-13567. doi: 10.1021/acs.jmedchem.3c00852. Epub 2023 Sep 26. PubMed
Exploring Fatty Acid Mimetics as NR4A Ligands. Stiller T, Merk D. J Med Chem. 2023 Nov 23;66(22):15362-15369. doi: 10.1021/acs.jmedchem.3c01467. Epub 2023 Nov 2. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.